Free Trial

NewAmsterdam Pharma (NAMSW) SEC Filings & 10K Form

NewAmsterdam Pharma logo
$13.78 +0.34 (+2.52%)
As of 08/22/2025 03:55 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent NewAmsterdam Pharma SEC Filings

DateFilerForm TypeView
08/20/2025
4:28 PM
Frazier Life Sciences X, L.P. (Filed by)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
Form SCHEDULE 13D/A
08/18/2025
7:00 AM
NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2025
11:56 AM
Capital World Investors (Filed by)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
Form SCHEDULE 13G/A
08/12/2025
3:30 PM
Forbion Capital Fund IV Cooperatief U.A. (Filed by)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
Form SCHEDULE 13D/A
08/06/2025
6:00 AM
NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2025
6:00 AM
NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2025
7:25 AM
NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/14/2025
3:12 PM
NAP PoolCo B.V. (Reporting)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/11/2025
3:25 PM
NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2025
6:41 PM
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Topper James N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
3:42 PM
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Topper James N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
3:50 PM
Kling Douglas F (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
11:31 AM
NAP PoolCo B.V. (Reporting)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/11/2025
8:00 AM
NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/09/2025
6:28 AM
NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2025
3:35 PM
NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
3:40 PM
Kling Douglas F (Reporting)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/13/2025
10:44 AM
Capital World Investors (Filed by)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
Form SCHEDULE 13G
05/08/2025
3:28 PM
NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
Form ARS
05/08/2025
7:00 AM
NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
7:00 AM
NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2025
6:36 AM
NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/21/2025
4:41 PM
LANGE LOUIS G (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2025
4:34 PM
Gulfo Adele M. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/17/2025
4:36 PM
Gulfo Adele M. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2025
4:41 PM
Kling Douglas F (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2025
4:06 PM
NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2025
4:36 PM
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Topper James N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2025
4:18 PM
Kling Douglas F (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2025
4:20 PM
Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2025
4:24 PM
LANGE LOUIS G (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2025
4:29 PM
Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
5:19 PM
Davidson Michael H. (Reporting)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/26/2025
5:00 PM
Kling Douglas F (Reporting)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/26/2025
3:27 PM
Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:29 PM
Kling Douglas F (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
11:15 PM
NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
Form EFFECT
03/10/2025
3:52 PM
NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
Form 424B3
03/06/2025
4:32 PM
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Topper James N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
5:10 PM
Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
5:54 PM
Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
When the levee breaks (Ad)

The U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was projected. According to Porter Stansberry, this is panic-level borrowing… and a clear sign we’re nearing America’s financial breaking point. In his latest emergency briefing, Porter outlines why the cracks in our system are widening fast—and how Trump’s policies may be accelerating the collapse. More importantly, he reveals three moves you can make now to protect and potentially grow your wealth before the levee breaks.tc pixel

Click here to watch the urgent broadcast and get ahead of what’s coming.
02/28/2025
4:06 PM
NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/26/2025
7:00 AM
NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2025
7:00 AM
NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/20/2025
4:24 PM
Kling Douglas F (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:42 PM
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SCHEDULE 13G/A
01/31/2025
4:00 PM
Kling Douglas F (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
4:25 PM
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Somaiya Mayur Ian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
4:16 PM
Kling Douglas F (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
4:09 PM
Kling Douglas F (Reporting)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/27/2025
3:52 PM
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
Somaiya Mayur Ian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/10/2025
3:26 PM
NAP PoolCo B.V. (Reporting)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/10/2025
7:27 AM
NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
4:58 PM
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
van der Kamp Hilde Johanna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
5:03 PM
Lewis William (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
5:08 PM
McKenna Mark C. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
5:09 PM
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Smither John W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
4:57 PM
LANGE LOUIS G (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
4:21 PM
Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
4:21 PM
Davidson Michael H. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
4:21 PM
Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
4:08 PM
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Somaiya Mayur Ian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
4:10 PM
Kling Douglas F (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
4:12 PM
JONES WILLIAM A JR (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:29 PM
NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/06/2025
4:57 PM
Kling Douglas F (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
4:48 PM
Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
4:51 PM
JONES WILLIAM A JR (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
4:53 PM
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Somaiya Mayur Ian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
4:54 PM
Audet Juliette Berangere (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
4:56 PM
Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
3:15 PM
Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
3:15 PM
Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
3:15 PM
Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
3:25 PM
Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
3:15 PM
Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
4:35 PM
BCLS II Investco, LP (Filed by)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
Form SC 13D/A
12/17/2024
4:05 PM
Bain Capital Life Sciences Fund II, L.P. (Reporting)
Bain Capital Life Sciences Fund III, L.P. (Reporting)
Bain Capital Life Sciences III General Partner, LLC (Reporting)
Bain Capital Life Sciences Investors II, LLC (Reporting)
Bain Capital Life Sciences Investors, LLC (Reporting)
BCIP Life Sciences Associates, LP (Reporting)
BCLS Fund III Investments GP, LLC (Reporting)
BCLS Fund III Investments, LP (Reporting)
BCLS II Investco , LLC (0001819101) (Reporting)
BCLS II Investco, LP (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
3:00 PM
Forbion Capital Fund IV Cooperatief U.A. (Filed by)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
Form SC 13D/A
12/17/2024
9:28 AM
Frazier Life Sciences X, L.P. (Filed by)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
Form SC 13D/A
12/16/2024
3:15 PM
Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
7:28 AM
NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2024
5:33 AM
NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
Form 424B5
12/12/2024
3:15 PM
Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
6:57 PM
NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
Form S-3MEF
12/10/2024
3:48 PM
NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
Form 424B5
12/10/2024
6:24 AM
NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2024
6:07 AM
NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
3:29 PM
Forbion Capital Fund IV Cooperatief U.A. (Filed by)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
Form SC 13D/A
11/14/2024
4:46 PM
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G/A
11/06/2024
7:00 AM
NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Elon Musk’s New Technology (Ad)

Elon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a new AI supercomputer—what one industry CEO calls “the most powerful in the world.” Musk says this tech will drive the next wave of American innovation. You can’t invest in the supercomputer directly—but there’s a backdoor way to access the company powering it. It’s smaller than Tesla or Nvidia, but both rely on it for future growth.tc pixel

Get the full details on the AI company behind Musk’s next big move.
11/06/2024
7:00 AM
NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/28/2024
7:02 AM
NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
Form 20-F/A
10/18/2024
3:51 PM
NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2024
4:01 PM
Davidson Michael H. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
4:23 PM
Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
4:12 PM
Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/30/2024
4:22 PM
Audet Juliette Berangere (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NAMSW) was last updated on 8/24/2025 by MarketBeat.com Staff
From Our Partners